News + Filings Transactions Holdings
All 13F 13D/G Other
|
Knoll Capital Management, LLC
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/14/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| Knoll Capital Management, LP reports a 7.1% stake in Corbus Pharmaceuticals Holdings, Inc. |
02/14/2019 |
SC 13G/A
| Knoll Capital Management, LP reports a 7.9% stake in Corbus Pharmaceuticals Holdings, Inc. |
02/14/2018 |
SC 13G/A
| Knoll Capital Management, LP reports a 6.9% stake in Corbus Pharmaceuticals Holdings, Inc. |
02/14/2018 |
SC 13G/A
| Knoll Capital Management, LP reports a 5% stake in Abeona Therapeutics, Inc |
03/06/2017 |
SC 13G/A
| Knoll Capital Management, LP reports a 7.3% stake in Corbus Pharmaceuticals Holdings, Inc. |
02/14/2017 |
SC 13G/A
| Corbus Pharmaceuticals Holdings, Inc. reports a 5.8% stake in _)* Corbus Pharmaceuticals Holdings, Inc. |
02/14/2017 |
SC 13G/A
| Knoll Capital Management, LP reports a 5.8% stake in _)* Corbus Pharmaceuticals Holdings, Inc. |
02/14/2017 |
SC 13G/A
| Knoll Capital Management, LP reports a 8.2% stake in Ritter Pharmaceuticals, Inc. |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2017 |
SC 13G/A
| ALCOBRA LTD. reports a 4.4% stake in Alcobra Ltd, |
02/14/2017 |
SC 13G/A
| Ampio Pharmaceuticals, Inc. reports a 4.8% stake in Ampio Pharmaceuticals, Inc |
02/14/2017 |
SC 13G/A
| Synthetic Biologics, Inc. reports a 2.6% stake in Synthetic Biologics, Inc. |
02/11/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/11/2011 |
SC 13G/A
| MEDIVATION, INC. reports a 5.7% stake in Medivation, Inc. |
02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
|
|